Study of XL309 (ISM3091) in Patients With Advanced Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumor
Interventions: DRUG: XL309 (ISM3091)
Sponsor: Exelixis